The joint venture — the first in the field of biotechnology — would produce vaccines to fight cancer developed with Cuban technology. U.S. clinical trials of the CIMAvax vaccine against lung cancer began in January, under an authorization from the Food and Drug Administration.
The joint venture — the first in the field of biotechnology — would produce vaccines to fight cancer developed with Cuban technology. U.S. clinical trials of the CIMAvax vaccine against lung cancer began in January, under an authorization from the Food and Drug Administration. Courtesy
The joint venture — the first in the field of biotechnology — would produce vaccines to fight cancer developed with Cuban technology. U.S. clinical trials of the CIMAvax vaccine against lung cancer began in January, under an authorization from the Food and Drug Administration. Courtesy

Cuba

February 14, 2017 4:02 PM

Proposed joint venture to produce and sell Cuban vaccines to treat cancer seeks investors

Suggested for you

  Comments  

Videos

Waiting for Water

Cuba on Twitter

Nation & World Videos